Watson, J&J Settle Over Birth Control Generic

Law360, New York (February 8, 2012, 2:17 PM EST) -- Watson Laboratories on Wednesday announced that it has entered into an agreement with a Johnson & Johnson subsidiary by which the company will issue to Watson a generic version of J&J's Ortho Tri-Cyclen Lo birth control drug, days after the parties settled a related patent infringement suit in New Jersey.

Beginning on December 31, 2015, Watson will be authorized to sell the generic version of J&J's oral contraceptive pill, as per a supply agreement struck between the companies, Watson said in its notice.

The announcement comes...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.